Feline calicivirus and other respiratory pathogens in cats with Feline calicivirus-related symptoms and in clinically healthy cats in Switzerland

BMC Veterinary Research

Regina Hofmann-Lehmann³  Hans Lutz²  Anou Dreyfus⁵  Sonja Hartnack⁵  Felicitas S. Boretti¹  Marina L. Meli⁴  Barbara Willi¹  Alice Berger² 

[1] Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland;Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland;Present address: Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Winterthurerstr. 260, Zurich, 8057, Switzerland;Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland;Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland

关键词: Multivariable analysis;    Oral ulcerations;    Gingivostomatitis;    Upper respiratory tract disease;    Vaccination;    Risk factors;    Chlamydophila felis;    Mycoplasma felis;    Feline herpesvirus-1;    Feline calicivirus;   

Others  :  1233997
DOI  :  10.1186/s12917-015-0595-2

 received in 2015-02-07, accepted in 2015-11-09,  发布年份 2015

【 摘 要 】

Background

Cats with feline calicivirus (FCV)-related symptoms are commonly presented to veterinary practitioners. Various clinical manifestations have been attributed to FCV, i.e. upper respiratory tract disease (URTD), oral ulcerations, gingivostomatitis, limping syndrome and virulent systemic disease. Additionally, healthy cats can shed FCV. The aims of this study were 1) to investigate the frequency of FCV in cats with FCV-related symptoms and in healthy cats in Switzerland, 2) to assess risk and protective factors for infection, such as signalment, housing conditions, vaccination, and co-infection with URTD-associated pathogens, and 3) to address the association between clinical symptoms and FCV infection.

Results

Oropharyngeal, nasal and conjunctival swabs were collected in 24 veterinary practices from 200 FCV-suspect and 100 healthy cats originating from 19 cantons of Switzerland. The samples were tested for FCV using virus isolation and reverse-transcription real-time quantitative polymerase chain reaction (qPCR) and for feline herpesvirus-1 (FHV-1), Mycoplasma felis, Chlamydophila felis, Bordetella bronchiseptica using real-time qPCR. Within the two populations (FCV-suspect/healthy), the observed PCR prevalences were: FCV 45 %/8 %, FHV-1 20 %/9 %, C. felis 8 %/1 %, B. bronchiseptica 4 %/2 %, M. felis 47 %/31 % and any co-infections thereof 40 %/14 %. Based on multivariable regression models amongst FCV-suspect cats (odds ratio [95 % confidence interval]), co-infection with M. felis (1.75 [0.97; 3.14]), group housing (2.11 [1.02; 4.34]) and intact reproductive status (1.80 [0.99; 3.28]) were found to be risk factors for FCV infection. In healthy cats, intact reproductive status (22.2 [1.85; 266.7]) and group housing (46.4 [5.70; 377.7]) were found to be associated with FCV infection. Based on an univariable approach, FCV-suspect cats were found to be significantly less often FCV-positive when vaccinated (0.48 [0.24; 0.94]). Oral ulcerations, salivation, gingivitis and stomatitis, but not classical signs of URTD were significantly associated with FCV infection (all p < 0.001).

Conclusions

FCV was detected in less than half of the cats that were judged FCV-suspect by veterinary practitioners. For a clinical diagnosis, FCV-related symptoms should be revisited. FCV infection was present in some healthy cats, underlining the importance of asymptomatic carriers in FCV epidemiology. To reduce FCV-related problems in multi-cat environments, reduction of group size in addition to the generally recommended vaccination are advocated.

【 授权许可】

   
2015 Berger et al.

【 图 表 】

Fig. 1.

Fig. 2.

【 参考文献 】

• [1]Harrison TM, Sikarskie J, Kruger J, Wise A, Mullaney TP, Kiupel M et al.. Systemic calicivirus epidemic in captive exotic felids. J Zoo Wildl Med. 2007; 38(2):292-9.
• [2]Radford AD, Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T et al.. Feline calicivirus infection. ABCD guidelines on prevention and management. J Feline Med Surg. 2009; 11(7):556-64.
• [3]Reubel GH, Hoffmann DE, Pedersen NC. Acute and chronic faucitis of domestic cats. A feline calicivirus-induced disease. Vet Clin North Am Small Anim Pract. 1992; 22(6):1347-60.
• [4]Wardley RC, Povey RC. The pathology and sites of persistence associated with three different strains of feline calicivirus. Res Vet Sci. 1977; 23(1):15-9.
• [5]Belgard S, Truyen U, Thibault JC, Sauter-Louis C, Hartmann K. Relevance of feline calicivirus, feline immunodeficiency virus, feline leukemia virus, feline herpesvirus and Bartonella henselae in cats with chronic gingivostomatitis. Berl Munch Tierarztl Wochenschr. 2010; 123(9–10):369-76.
• [6]TerWee J, Lauritzen AY, Sabara M, Dreier KJ, Kokjohn K. Comparison of the primary signs induced by experimental exposure to either a pneumotrophic or a ‘limping’ strain of feline calicivirus. Vet Microbiol. 1997; 56(1–2):33-45.
• [7]Dawson S, Bennett D, Carter SD, Bennett M, Meanger J, Turner PC et al.. Acute arthritis of cats associated with feline calicivirus infection. Res Vet Sci. 1994; 56(2):133-43.
• [8]Levy JK, Marsh A. Isolation of calicivirus from the joint of a kitten with arthritis. J Am Veterinary Medical Assoc. 1992; 201(5):753-5.
• [9]Pedersen NC, Elliott JB, Glasgow A, Poland A, Keel K. An isolated epizootic of hemorrhagic-like fever in cats caused by a novel and highly virulent strain of feline calicivirus. Vet Microbiol. 2000; 73(4):281-300.
• [10]Schorr-Evans EM, Poland A, Johnson WE, Pedersen NC. An epizootic of highly virulent feline calicivirus disease in a hospital setting in New England. J Feline Med Surg. 2003; 5(4):217-26.
• [11]Coyne KP, Jones BR, Kipar A, Chantrey J, Porter CJ, Barber PJ et al.. Lethal outbreak of disease associated with feline calicivirus infection in cats. Vet Rec. 2006; 158(16):544-50.
• [12]Reynolds BS, Poulet H, Pingret JL, Jas D, Brunet S, Lemeter C et al.. A nosocomial outbreak of feline calicivirus associated virulent systemic disease in France. J Feline Med Surg. 2009; 11(8):633-44.
• [13]Schulz BS, Hartmann K, Unterer S, Eichhorn W, Majzoub M, Homeier-Bachmann T et al.. Two outbreaks of virulent systemic feline calicivirus infection in cats in Germany. Berl Munch Tierarztl Wochenschr. 2011; 124(5–6):186-93.
• [14]Cai Y, Fukushi H, Koyasu S, Kuroda E, Yamaguchi T, Hirai K. An etiological investigation of domestic cats with conjunctivitis and upper respiratory tract disease in Japan. J Vet Med Sci. 2002; 64(3):215-9.
• [15]Helps CR, Lait P, Damhuis A, Bjornehammar U, Bolta D, Brovida C et al.. Factors associated with upper respiratory tract disease caused by feline herpesvirus, feline calicivirus, Chlamydophila felis and Bordetella bronchiseptica in cats: experience from 218 European catteries. Vet Rec. 2005; 156(21):669-73.
• [16]Bannasch MJ, Foley JE. Epidemiologic evaluation of multiple respiratory pathogens in cats in animal shelters. J Feline Med Surg. 2005; 7(2):109-19.
• [17]Hoover EA, Kahn DE. Experimentally induced feline calicivirus infection: clinical signs and lesions. J Am Veterinary Medical Assoc. 1975; 166(5):463-8.
• [18]Harbour DA, Howard PE, Gaskell RM. Isolation of feline calicivirus and feline herpesvirus from domestic cats 1980 to 1989. Vet Rec. 1991; 128(4):77-80.
• [19]Binns SH, Dawson S, Speakman AJ, Cuevas LE, Hart CA, Gaskell CJ et al.. A study of feline upper respiratory tract disease with reference to prevalence and risk factors for infection with feline calicivirus and feline herpesvirus. J Feline Med Surg. 2000; 2(3):123-33.
• [20]Foster SF, Barrs VR, Martin P, Malik R. Pneumonia associated with Mycoplasma spp in three cats. Aust Vet J. 1998; 76(7):460-4.
• [21]Foley JE, Rand C, Bannasch MJ, Norris CR, Milan J. Molecular epidemiology of feline bordetellosis in two animal shelters in California. USA Prev Vet Med. 2002; 54(2):141-56.
• [22]Hartmann A, Hartmann K. Treatment and management of Chlamydophila felis infections in cats. Tierarztl Prax Ausg K Kleintiere Heimtiere. 2010; 38(4):217-26.
• [23]Masubuchi K, Nosaka H, Iwamoto K, Kokubu T, Yamanaka M, Shimizu Y. Experimental infection of cats with Chlamydophila felis. J Vet Med Sci. 2002; 64(12):1165-8.
• [24]McArdle HC, Dawson S, Coutts AJ, Bennett M, Hart CA, Ryvar R et al.. Seroprevalence and isolation rate of Bordetella bronchiseptica in cats in the UK. Vet Rec. 1994; 135(21):506-7.
• [25]Helps C, Lait P, Tasker S, Harbour D. Melting curve analysis of feline calicivirus isolates detected by real-time reverse transcription PCR. J Virol Methods. 2002; 106(2):241-4.
• [26]Abd-Eldaim MM, Wilkes RP, Thomas KV, Kennedy MA. Development and validation of a TaqMan real-time reverse transcription-PCR for rapid detection of feline calicivirus. Arch Virol. 2009; 154(4):555-60.
• [27]Sykes JE, Studdert VP, Browning GF. Detection and strain differentiation of feline calicivirus in conjunctival swabs by RT-PCR of the hypervariable region of the capsid protein gene. Arch Virol. 1998; 143(7):1321-34.
• [28]Marsilio F, Di Martino B, Decaro N, Buonavoglia C. A novel nested PCR for the diagnosis of calicivirus infections in the cat. Vet Microbiol. 2005; 105(1):1-7.
• [29]Wilhelm S, Truyen U. Real-time reverse transcription polymerase chain reaction assay to detect a broad range of feline calicivirus isolates. J Virol Methods. 2006; 133(1):105-8.
• [30]Orr CM, Gaskell CJ, Gaskell RM. Interaction of a combined feline viral rhinotracheitis-feline calicivirus vaccine and the FVR carrier state. Vet Rec. 1978; 103(10):200-2.
• [31]Bittle JL, Rubic WJ. Immunization against feline calicivirus infection. Am J Vet Res. 1976; 37(3):275-8.
• [32]Radford AD, Dawson S, Coyne KP, Porter CJ, Gaskell RM. The challenge for the next generation of feline calicivirus vaccines. Vet Microbiol. 2006; 117(1):14-8.
• [33]Lauritzen A, Jarrett O, Sabara M. Serological analysis of feline calicivirus isolates from the United States and United Kingdom. Vet Microbiol. 1997; 56(1–2):55-63.
• [34]Porter CJ, Radford AD, Gaskell RM, Ryvar R, Coyne KP, Pinchbeck GL et al.. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates. J Feline Med Surg. 2008; 10(1):32-40.
• [35]Addie D, Poulet H, Golder MC, McDonald M, Brunet S, Thibault JC et al.. Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK. Vet Rec. 2008; 163(12):355-7.
• [36]Poulet H, Brunet S, Leroy V, Chappuis G. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges. Vet Microbiol. 2005; 106(1–2):17-31.
• [37]Huang C, Hess J, Gill M, Hustead D. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease. J Feline Med Surg. 2010; 12(2):129-37.
• [38]Masubuchi K, Wakatsuki A, Iwamoto K, Takahashi T, Kokubu T, Shimizu M. Immunological and genetic characterization of feline caliciviruses used in the development of a new trivalent inactivated vaccine in Japan. J Veterinary Medical Science. 2010; 72(9):1189-94.
• [39]Schweizerische Eidgenossenschaft: Schweizer Tierschutzgesetzt (TSchG). 2008. https://www.admin.ch/opc/de/classified-compilation/20022103/index.html. Accessed 18 August 2015.
• [40]Gerriets W, Joy N, Huebner-Guthardt J, Eule JC. Feline calicivirus: a neglected cause of feline ocular surface infections? Vet Ophthalmol. 2012; 15(3):172-9.
• [41]Willi B, Boretti FS, Baumgartner C, Tasker S, Wenger B, Cattori V et al.. Prevalence, risk factor analysis, and follow-up of infections caused by three feline hemoplasma species in cats in Switzerland. J Clinical Microbiology. 2006; 44(3):961-9.
• [42]Lutz H, Lehmann R, Winkler G, Kottwitz B, Dittmer A, Wolfensberger C et al.. Feline immunodeficiency virus in Switzerland: clinical aspects and epidemiology in comparison with feline leukemia virus and coronaviruses. Schweiz Arch Tierheilkd. 1990; 132(5):217-25.
• [43]Vogtlin A, Fraefel C, Albini S, Leutenegger CM, Schraner E, Spiess B et al.. Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR. J Clinical Microbiology. 2002; 40(2):519-23.
• [44]Helps C, Reeves N, Egan K, Howard P, Harbour D. Detection of Chlamydophila felis and feline herpesvirus by multiplex real-time PCR analysis. J Clinical Microbiology. 2003; 41(6):2734-6.
• [45]Soderlund R, Bolske G, Holst BS, Aspan A. Development and evaluation of a real-time polymerase chain reaction method for the detection of Mycoplasma felis. J Vet Diagn Invest. 2011; 23(5):890-3.
• [46]Tandon R, Cattori V, Gomes-Keller MA, Meli ML, Golder MC, Lutz H et al.. Quantitation of feline leukaemia virus viral and proviral loads by TaqMan real-time polymerase chain reaction. J Virol Methods. 2005; 130(1–2):124-32.
• [47]Klein D, Leutenegger CM, Bahula C, Gold P, Hofmann-Lehmann R, Salmons B et al.. Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J Acquired Immune Deficiency Syndromes. 2001; 26(1):8-20.
• [48]R-Core-Team. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2015. http://www.R-project.org. Accessed 11 July 2015 .
• [49]Stekhoven D, Buehlmann P. MissForest - non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012; 28:112-8.
• [50]Venables W, Ripley B. Modern Applied Statistics with S. 4th ed. Springer, New York; 2002.
• [51]QGIS Development Team. QGIS Geographic Information System. Open Source Geospatial Foundation Project. Brighton. 2014. http://qgis.osgeo.org. Accessed 18 August 2015.
• [52]Wardley RC, Gaskell RM, Povey RC. Feline respiratory viruses--their prevalence in clinically healthy cats. J Small Anim Pract. 1974; 15(9):579-86.
• [53]Pesavento PA, Chang KO, Parker JS. Molecular virology of feline calicivirus. Vet Clin North Am Small Anim Pract. 2008; 38(4):775-86.
• [54]Lesbros C, Martin V, Najbar W, Sanquer A, McGahie D, Eun HM et al.. Protective efficacy of the calicivirus valency of the leucofeligen vaccine against a virulent heterologous challenge in kittens. Vet Med Int. 2013; 2013:232397.
• [55]Coyne KP, Christley RM, Pybus OG, Dawson S, Gaskell RM, Radford AD. Large-scale spatial and temporal genetic diversity of feline calicivirus. J Virol. 2012; 86(20):11356-67.
• [56]Radford AD, Dawson S, Ryvar R, Coyne K, Johnson DR, Cox MB et al.. High genetic diversity of the immunodominant region of the feline calicivirus capsid gene in endemically infected cat colonies. Virus Genes. 2003; 27(2):145-55.
• [57]Zicola A, Saegerman C, Quatpers D, Viandier J, Thiry E. Feline herpesvirus 1 and feline calicivirus infections in a heterogeneous cat population of a rescue shelter. J Feline Med Surg. 2009; 11(12):1023-7.
• [58]Radford AD, Turner PC, Bennett M, McArdle F, Dawson S, Glenn MA et al.. Quasispecies evolution of a hypervariable region of the feline calicivirus capsid gene in cell culture and in persistently infected cats. J Gen Virol. 1998; 79(Pt 1):1-10.
• [59]Coyne KP, Edwards D, Radford AD, Cripps P, Jones D, Wood JL et al.. Longitudinal molecular epidemiological analysis of feline calicivirus infection in an animal shelter: a model for investigating calicivirus transmission within high-density, high-turnover populations. J Clinical Microbiology. 2007; 45(10):3239-44.
• [60]Addie D, Belak S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T et al.. Feline infectious peritonitis. ABCD guidelines on prevention and management. J Feline Med Surg. 2009; 11(7):594-604.
• [61]Foley JE, Poland A, Carlson J, Pedersen NC. Risk factors for feline infectious peritonitis among cats in multiple-cat environments with endemic feline enteric coronavirus. J Am Veterinary Medical Assoc. 1997; 210(9):1313-8.
• [62]Gaskell CJ, Radford A, Dawson S. Feline infectious respiratory disease. In: Feline Medicine and Therapeutics. 3rd ed. Chandler EA, Gaskell CJ, Gaskell RM, editors. Blackwell Publishing, Oxford; 2004: p.577-95.
• [63]Girard N, Servet E, Biourge V, Hennet P. Periodontal health status in a colony of 109 cats. J Vet Dent. 2009; 26(3):147-55.
• [64]Gesellschaft Schweizerischer Tierärztinnen und Tierärzte GST, Schweizerische Vereinigung für Kleintiermedizin (SVK). Geliebt! Geimpft? Gesunde Tiere machen Freude. http://www.gstsvs.ch/de/themen-standpunkte/aktuelle-meldungen/news-search/newsdetail/article/2009/04/30/title/geliebt-gei.html. Accessed 5 February 2015.
• [65]Horzinek MC, Thiry E. Vaccines and vaccination: the principles and the polemics. J Feline Med Surg. 2009; 11(7):530-7.